Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000144314) titled 'Delivering a lung cancer screening pathway co-designed with Maori Providers' on Feb. 4.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Efficacy
Primary Sponsor: University of Otago
Condition:
Lung Cancer
Lung Cancer
Public Health - Other public health
Cancer - Lung - Non small cell
Intervention:
This is a mixed (quantitative and qualitative) methods prospective cohort study including people offered lung cancer screening and an evaluation of participant/whanau and Maori Provider staf...